Richard Pilnik Net Worth & Insider Trades
Richard Pilnik - Director, Diamedica Therapeutics Inc
What is Richard Pilnik's Net Worth?
The current estimated net worth of Diamedica Therapeutics Inc's Director, Richard Pilnik, is estimated to be about $104.05K . Richard Pilnik owns about 154,327 units of Diamedica Therapeutics Inc common stock. In the last 5 years at Diamedica Therapeutics Inc, Richard Pilnik has sold an estimated value of $0 worth.
What is Richard Pilnik's Past Insider Trading?
Richard Pilnik's largest purchase order was 10,000 units , worth over $53.7K on December 4, 2020. In total, Richard Pilnik has made about 13 transactions over 5 years of their time at Diamedica Therapeutics Inc. Richard Pilnik usually trades in June, January and December, with the busiest year in 2019, 2022 and 2021. The most recent transaction was a purchase order of 35,000 units , worth over $48.49K on December 5, 2022.
Richard Pilnik
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Richard Pilnik's' Mailing Address?
- Mailing address is 2 Carlson Parkway Suite 260 Minneapolis MN 55447 MN
Diamedica Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Rick Pauls | 2020 | $455,013 | - | $190,624 | $217,716 | $14,850 | $878,203 |
| Rick Pauls | 2019 | $420,000 | - | $890,736 | $178,000 | $14,650 | $733,707 |
| Scott Kellen | 2020 | $276,075 | - | $119,140 | $79,238 | $14,850 | $489,303 |
| Scott Kellen | 2019 | $262,500 | - | $336,557 | $64,800 | $13,950 | $677,807 |
| Harry Alcorn, Jr., Pharm.D. | 2020 | $291,413 | - | $119,140 | $83,662 | $14,850 | $509,065 |
| Harry Alcorn, Jr., Pharm.D. | 2019 | $273,750 | - | $421,750 | $68,400 | $14,400 | $778,300 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1401040/000143774921014066/dmtp20210406_def14a.htm
What are Diamedica Therapeutics Inc's Past Insider Trades?
Diamedica Therapeutics Inc's most recent insider trade came on December 12, 2022 by Michael Randall Giuffre who bought 57,079 units worth $81.02K . In the last 4 years, insiders at Diamedica Therapeutics Inc have sold an estimated value of $3.53M and bought an estimated value of $5.53M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Michael Randall Giuffre, Director, Richard Pilnik, Director, and Scott Kellen, CFO and Secretary .
DiaMedica Therapeutics Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||